Redwood Wealth Management Group’s Precision BioSciences DTIL Stock Holding History

Redwood Wealth Management Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,378	Closed	-$150K	–	415
2024 Q2	$150K	Buy	+15,378	New	+$181K	0.11%	144
2024 Q1	–	Sell	-7,083	Closed	-$77.6K	–	122
2023 Q4	$77.6K	Buy	7,083 +523	+8%	+$5.64K	0.09%	124
2023 Q3	$67.2K	Buy	6,560 +537	+9%	+$8.25K	0.08%	125
2023 Q2	$95K	Sell	6,023 -46	-0.8%	-$1.05K	0.11%	129
2023 Q1	$137K	Buy	6,069 +244	+4%	+$8.04K	0.16%	129
2022 Q4	$208K	Buy	+5,825	New	+$230K	0.26%	108

Other funds holding DTIL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redwood Wealth Management Group's DTIL Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of Precision BioSciences (DTIL) in Q3 2024, closing a stake of 15,378 shares — an estimated $150K sold.

Redwood Wealth Management Group first reported a position in DTIL in Q4 2022 and held it in 6 quarters. The position peaked at $208K in Q4 2022. 51 funds tracked by Wall St. Rank hold DTIL as of Q3 2024.

Redwood Wealth Management Group reported no remaining Precision BioSciences position as of Q3 2024 after selling out during the quarter.
Redwood Wealth Management Group sold 15,378 Precision BioSciences shares in Q3 2024, an estimated $150K.
Redwood Wealth Management Group first reported a position in Precision BioSciences in Q4 2022 and held it in 6 quarters.
Redwood Wealth Management Group's Precision BioSciences position peaked at $208K in Q4 2022.
51 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.